-
1
-
-
0033858548
-
Clinical criteria and biochemical markers for the detection of systolic dysfunction
-
Yamamoto K, Burnett JC. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail. 2000;6(3):194-200.
-
(2000)
J Card Fail
, vol.6
, Issue.3
, pp. 194-200
-
-
Yamamoto, K.1
Burnett, J.C.2
-
2
-
-
0042198675
-
B-type natriuretic peptide in cardiovascular disease
-
de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316-322.
-
(2003)
Lancet
, vol.362
, Issue.9380
, pp. 316-322
-
-
de Lemos, J.A.1
McGuire, D.K.2
Drazner, M.H.3
-
3
-
-
1642451712
-
Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review
-
Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004;50(1):33-50.
-
(2004)
Clin Chem
, vol.50
, Issue.1
, pp. 33-50
-
-
Clerico, A.1
Emdin, M.2
-
4
-
-
0026639762
-
Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure
-
Elsner D, Müntze A, Kromer EP, Riegger GA. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. Am J Cardiol. 1992;70(4):494-498.
-
(1992)
Am J Cardiol
, vol.70
, Issue.4
, pp. 494-498
-
-
Elsner, D.1
Müntze, A.2
Kromer, E.P.3
Riegger, G.A.4
-
5
-
-
0035807597
-
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
-
de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345(14):1014-1021.
-
(2001)
N Engl J Med
, vol.345
, Issue.14
, pp. 1014-1021
-
-
de Lemos, J.A.1
Morrow, D.A.2
Bentley, J.H.3
-
6
-
-
0344608881
-
-
Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 [published correction appears in J Am Coll Cardiol. 2003;41(10):1852]. J Am Coll Cardiol. 2003;41(8):1264-1272.
-
Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 [published correction appears in J Am Coll Cardiol. 2003;41(10):1852]. J Am Coll Cardiol. 2003;41(8):1264-1272.
-
-
-
-
7
-
-
0029948712
-
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
-
Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996;93(11):1963-1969.
-
(1996)
Circulation
, vol.93
, Issue.11
, pp. 1963-1969
-
-
Omland, T.1
Aakvaag, A.2
Bonarjee, V.V.3
-
8
-
-
0037083217
-
Prognostic value of N-terminal proatrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
-
Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal proatrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol. 2002;89(4):463-465.
-
(2002)
Am J Cardiol
, vol.89
, Issue.4
, pp. 463-465
-
-
Omland, T.1
de Lemos, J.A.2
Morrow, D.A.3
-
9
-
-
12144262560
-
-
Silver MA, Maisel A, Yancy CW, et al; BNP Consensus Panel. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases [published correction appears in Congest Heart Fail. 2005;11(2):102]. Congest Heart Fail. 2004;10(5)(suppl 3):1-30.
-
Silver MA, Maisel A, Yancy CW, et al; BNP Consensus Panel. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases [published correction appears in Congest Heart Fail. 2005;11(2):102]. Congest Heart Fail. 2004;10(5)(suppl 3):1-30.
-
-
-
-
10
-
-
0041807669
-
Future of biomarkers in acute coronary syndromes: Moving toward a multimarker strategy
-
Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation. 2003;108(3):250-252.
-
(2003)
Circulation
, vol.108
, Issue.3
, pp. 250-252
-
-
Morrow, D.A.1
Braunwald, E.2
-
11
-
-
4344713312
-
Brain natriuretic peptide: A potential marker for mortality in septic shock
-
Castillo JR, Zagler A, Carrillo-Jimenez R, Hennekens CH. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int J Infect Dis. 2004;8(5):271-274.
-
(2004)
Int J Infect Dis
, vol.8
, Issue.5
, pp. 271-274
-
-
Castillo, J.R.1
Zagler, A.2
Carrillo-Jimenez, R.3
Hennekens, C.H.4
-
12
-
-
0033135184
-
Myocardial dysfunction in sepsis: Mechanisms and therapeutic implications
-
Price S, Anning PB, Mitchell JA, Evans TW. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J. 1999;20(10):715-724.
-
(1999)
Eur Heart J
, vol.20
, Issue.10
, pp. 715-724
-
-
Price, S.1
Anning, P.B.2
Mitchell, J.A.3
Evans, T.W.4
-
13
-
-
0036892344
-
Clinical review: Myocardial depression in sepsis and septic shock
-
Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care. 2002;6(6):500-508.
-
(2002)
Crit Care
, vol.6
, Issue.6
, pp. 500-508
-
-
Court, O.1
Kumar, A.2
Parrillo, J.E.3
Kumar, A.4
-
14
-
-
10744233555
-
Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction
-
Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003;29(10):1696-1702.
-
(2003)
Intensive Care Med
, vol.29
, Issue.10
, pp. 1696-1702
-
-
Witthaut, R.1
Busch, C.2
Fraunberger, P.3
-
15
-
-
23844432343
-
Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients
-
Hoffmann U, Brueckmann M, Bertsch T, et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab. 2005;51(7-8):373-379.
-
(2005)
Clin Lab
, vol.51
, Issue.7-8
, pp. 373-379
-
-
Hoffmann, U.1
Brueckmann, M.2
Bertsch, T.3
-
16
-
-
23044465859
-
Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis
-
Brueckmann M, Huhle G, Lang S, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005;112(4):527-534.
-
(2005)
Circulation
, vol.112
, Issue.4
, pp. 527-534
-
-
Brueckmann, M.1
Huhle, G.2
Lang, S.3
-
17
-
-
85176657961
-
-
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644- 1655.
-
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644- 1655.
-
-
-
-
18
-
-
0026874127
-
-
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
-
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
-
-
-
-
19
-
-
0020664293
-
The grading of sepsis
-
Elebute EA, Stoner HB. The grading of sepsis. Br J Surg. 1983;70(1):29-31.
-
(1983)
Br J Surg
, vol.70
, Issue.1
, pp. 29-31
-
-
Elebute, E.A.1
Stoner, H.B.2
-
20
-
-
0036905885
-
The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction
-
Peres Bota D, Melot C, Lopes Ferreira F, Nguyen Ba V, Vincent JL. The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med. 2002;28(11):1619-1624.
-
(2002)
Intensive Care Med
, vol.28
, Issue.11
, pp. 1619-1624
-
-
Peres Bota, D.1
Melot, C.2
Lopes Ferreira, F.3
Nguyen Ba, V.4
Vincent, J.L.5
-
21
-
-
41149141813
-
-
Triage BNP Test [package insert, San Diego, CA: Biosite Inc; 2003
-
Triage BNP Test [package insert]. San Diego, CA: Biosite Inc; 2003.
-
-
-
-
22
-
-
0028359997
-
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
-
Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90(1):195-203.
-
(1994)
Circulation
, vol.90
, Issue.1
, pp. 195-203
-
-
Yasue, H.1
Yoshimura, M.2
Sumida, H.3
-
23
-
-
0021279377
-
Profound but reversible myocardial depression in patients with septic shock
-
Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100(4):483-490.
-
(1984)
Ann Intern Med
, vol.100
, Issue.4
, pp. 483-490
-
-
Parker, M.M.1
Shelhamer, J.H.2
Bacharach, S.L.3
-
24
-
-
0022208356
-
Left ventricular performance in septic shock: Reversible segmental and global abnormalities
-
Ellrodt AG, Riedinger MS, Kimchi A, et al. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J. 1985;110(2):402-409.
-
(1985)
Am Heart J
, vol.110
, Issue.2
, pp. 402-409
-
-
Ellrodt, A.G.1
Riedinger, M.S.2
Kimchi, A.3
-
25
-
-
0023934409
-
Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock
-
Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE. Depressed left ventricular performance: response to volume infusion in patients with sepsis and septic shock. Chest. 1988;93(5):903-910.
-
(1988)
Chest
, vol.93
, Issue.5
, pp. 903-910
-
-
Ognibene, F.P.1
Parker, M.M.2
Natanson, C.3
Shelhamer, J.H.4
Parrillo, J.E.5
-
26
-
-
0025280618
-
Left ventricular diastolic function in sepsis
-
Jafri SM, Lavine S, Field BE, Bahorozian MT, Carlson RW. Left ventricular diastolic function in sepsis. Crit Care Med. 1990;18(7):709-714.
-
(1990)
Crit Care Med
, vol.18
, Issue.7
, pp. 709-714
-
-
Jafri, S.M.1
Lavine, S.2
Field, B.E.3
Bahorozian, M.T.4
Carlson, R.W.5
-
27
-
-
0031766341
-
Diastolic filling in human severe sepsis: An echocardiographic study
-
Munt B, Jue J, Gin K, Fenwick J, Tweeddale M. Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med. 1998;26(11):1829-1833.
-
(1998)
Crit Care Med
, vol.26
, Issue.11
, pp. 1829-1833
-
-
Munt, B.1
Jue, J.2
Gin, K.3
Fenwick, J.4
Tweeddale, M.5
-
28
-
-
0030950888
-
Left ventricular systolic and diastolic function in septic shock
-
Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med. 1997;23(5):553-560.
-
(1997)
Intensive Care Med
, vol.23
, Issue.5
, pp. 553-560
-
-
Poelaert, J.1
Declerck, C.2
Vogelaers, D.3
Colardyn, F.4
Visser, C.A.5
-
29
-
-
0024371424
-
A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock
-
Reilly JM, Cunnion RE, Burch-Whitman C, Parker MM, Shelhamer JH, Parrillo JE. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest. 1989;95(5):1072-1080.
-
(1989)
Chest
, vol.95
, Issue.5
, pp. 1072-1080
-
-
Reilly, J.M.1
Cunnion, R.E.2
Burch-Whitman, C.3
Parker, M.M.4
Shelhamer, J.H.5
Parrillo, J.E.6
-
30
-
-
0027920980
-
Pathogenetic mechanisms of septic shock
-
Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328(20):1471-1477.
-
(1993)
N Engl J Med
, vol.328
, Issue.20
, pp. 1471-1477
-
-
Parrillo, J.E.1
-
31
-
-
0032871721
-
Myocardial cell injury in septic shock
-
Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med. 1999;27(9):1775-1780.
-
(1999)
Crit Care Med
, vol.27
, Issue.9
, pp. 1775-1780
-
-
Turner, A.1
Tsamitros, M.2
Bellomo, R.3
-
32
-
-
0034919866
-
Elevation of troponin I in sepsis and septic shock
-
Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965-969.
-
(2001)
Intensive Care Med
, vol.27
, Issue.6
, pp. 965-969
-
-
Ammann, P.1
Fehr, T.2
Minder, E.I.3
Günter, C.4
Bertel, O.5
-
33
-
-
0035146371
-
α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock
-
Hartemink KJ, Groeneveld AB, de Groot MC, Strack van Schijndel RJ, van Kamp G, Thijs LG. α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med. 2001;29(1):80-87.
-
(2001)
Crit Care Med
, vol.29
, Issue.1
, pp. 80-87
-
-
Hartemink, K.J.1
Groeneveld, A.B.2
de Groot, M.C.3
Strack van Schijndel, R.J.4
van Kamp, G.5
Thijs, L.G.6
-
34
-
-
28944439267
-
A to Z Investigators. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
-
Morrow DA, de Lemos JA, Blazing MA, et al; A to Z Investigators. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA. 2005;294(22):2866-2871.
-
(2005)
JAMA
, vol.294
, Issue.22
, pp. 2866-2871
-
-
Morrow, D.A.1
de Lemos, J.A.2
Blazing, M.A.3
|